MedPath
FDA Approval

Lisinopril

FDA-approved pharmaceutical product with comprehensive regulatory information, manufacturing details, and complete labeling documentation.

FDA Approval Summary

Company
Effective Date
June 30, 2022
Labeling Type
HUMAN PRESCRIPTION DRUG LABEL
Lisinopril(10 mg in 1 1)

Registrants1

Companies and organizations registered with the FDA for this drug approval, including their contact information and regulatory details.

Prinston Pharmaceutical Inc.

967289799

Manufacturing Establishments1

FDA-registered manufacturing facilities and establishments involved in the production, packaging, or distribution of this drug product.

GENERICS BIDCO II, LLC

Solco healthcare U.S., LLC

Prinston Pharmaceutical Inc.

151228897

Products6

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

Lisinopril

Product Details

NDC Product Code
43547-416
Application Number
ANDA075743
Marketing Category
ANDA (C73584)
Route of Administration
Oral
Effective Date
September 20, 2018
STARCH, CORNInactive
Code: O8232NY3SJClass: IACT
DIBASIC CALCIUM PHOSPHATE DIHYDRATEInactive
Code: O7TSZ97GEPClass: IACT
Code: E7199S1YWRClass: ACTIBQuantity: 10 mg in 1 1
MAGNESIUM STEARATEInactive
Code: 70097M6I30Class: IACT
TALCInactive
Code: 7SEV7J4R1UClass: IACT
MANNITOLInactive
Code: 3OWL53L36AClass: IACT

Lisinopril

Product Details

NDC Product Code
43547-419
Application Number
ANDA075743
Marketing Category
ANDA (C73584)
Route of Administration
ORAL
Effective Date
September 20, 2018
DIBASIC CALCIUM PHOSPHATE DIHYDRATEInactive
Code: O7TSZ97GEPClass: IACT
Code: E7199S1YWRClass: ACTIMQuantity: 40 mg in 1 1
STARCH, CORNInactive
Code: O8232NY3SJClass: IACT
TALCInactive
Code: 7SEV7J4R1UClass: IACT
MAGNESIUM STEARATEInactive
Code: 70097M6I30Class: IACT
MANNITOLInactive
Code: 3OWL53L36AClass: IACT

Lisinopril

Product Details

NDC Product Code
43547-414
Application Number
ANDA075743
Marketing Category
ANDA (C73584)
Route of Administration
ORAL
Effective Date
September 20, 2018
Code: E7199S1YWRClass: ACTIMQuantity: 2.5 mg in 1 1
DIBASIC CALCIUM PHOSPHATE DIHYDRATEInactive
Code: O7TSZ97GEPClass: IACT
MAGNESIUM STEARATEInactive
Code: 70097M6I30Class: IACT
MANNITOLInactive
Code: 3OWL53L36AClass: IACT
STARCH, CORNInactive
Code: O8232NY3SJClass: IACT
TALCInactive
Code: 7SEV7J4R1UClass: IACT

Lisinopril

Product Details

NDC Product Code
43547-418
Application Number
ANDA075743
Marketing Category
ANDA (C73584)
Route of Administration
ORAL
Effective Date
September 20, 2018
Code: E7199S1YWRClass: ACTIBQuantity: 30 mg in 1 1
STARCH, CORNInactive
Code: O8232NY3SJClass: IACT
MAGNESIUM STEARATEInactive
Code: 70097M6I30Class: IACT
DIBASIC CALCIUM PHOSPHATE DIHYDRATEInactive
Code: O7TSZ97GEPClass: IACT
MANNITOLInactive
Code: 3OWL53L36AClass: IACT
TALCInactive
Code: 7SEV7J4R1UClass: IACT

Lisinopril

Product Details

NDC Product Code
43547-415
Application Number
ANDA075743
Marketing Category
ANDA (C73584)
Route of Administration
ORAL
Effective Date
September 20, 2018
Code: E7199S1YWRClass: ACTIMQuantity: 5 mg in 1 1
DIBASIC CALCIUM PHOSPHATE DIHYDRATEInactive
Code: O7TSZ97GEPClass: IACT
MAGNESIUM STEARATEInactive
Code: 70097M6I30Class: IACT
MANNITOLInactive
Code: 3OWL53L36AClass: IACT
STARCH, CORNInactive
Code: O8232NY3SJClass: IACT
TALCInactive
Code: 7SEV7J4R1UClass: IACT

Lisinopril

Product Details

NDC Product Code
43547-417
Application Number
ANDA075743
Marketing Category
ANDA (C73584)
Route of Administration
ORAL
Effective Date
September 20, 2018
DIBASIC CALCIUM PHOSPHATE DIHYDRATEInactive
Code: O7TSZ97GEPClass: IACT
Code: E7199S1YWRClass: ACTIMQuantity: 20 mg in 1 1
STARCH, CORNInactive
Code: O8232NY3SJClass: IACT
TALCInactive
Code: 7SEV7J4R1UClass: IACT
MAGNESIUM STEARATEInactive
Code: 70097M6I30Class: IACT
MANNITOLInactive
Code: 3OWL53L36AClass: IACT
© Copyright 2025. All Rights Reserved by MedPath